StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Regen BioPharma cash

Cash and short-term investments held at the end of each period.

Regen BioPharma's cash was $239 at Jun 30, 2026. For fiscal 2025 it was $69.56K, up 9614.4% from the year before. Over ten years it grew 6.1% a year on average. The highest annual figure on record is $727.16K in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Sep 30, 2025$69.56K+9614.4%
FY2024Sep 30, 2024$716-99.4%
FY2023Sep 30, 2023$121.04K+136.4%
FY2022Sep 30, 2022$51.20K-93.0%
FY2021Sep 30, 2021$727.16K–
FY2020Sep 30, 2020$0-100.0%
FY2019Sep 30, 2019$7.86K-2.0%
FY2018Sep 30, 2018$8.02K-97.0%
FY2017Sep 30, 2017$269.97K+987.6%
FY2016Sep 30, 2016$24.82K-35.7%
FY2015Sep 30, 2015$38.62K–
FY2014Sep 30, 2014$0-100.0%
FY2013Sep 30, 2013$115.99K+12466.8%
FY2012Sep 30, 2012$923–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$239-86.4%
Q2 FY2026CQ1 2026Mar 31, 2026$271-84.6%
Q1 FY2026CQ4 2025Dec 31, 2025$4.58K+3291.1%
Q4 FY2025CQ3 2025Sep 30, 2025$69.56K+9614.4%
Q3 FY2025CQ2 2025Jun 30, 2025$1.76K-97.2%
Q2 FY2025CQ1 2025Mar 31, 2025$1.76K-97.7%
Q1 FY2025CQ4 2024Dec 31, 2024$135-99.9%
Q4 FY2024CQ3 2024Sep 30, 2024$716-99.4%
Q3 FY2024CQ2 2024Jun 30, 2024$61.85K+8837.7%
Q2 FY2024CQ1 2024Mar 31, 2024$78.12K-10.9%
Q1 FY2024CQ4 2023Dec 31, 2023$124.50K+205.6%
Q4 FY2023CQ3 2023Sep 30, 2023$121.04K+136.4%
Q3 FY2023CQ2 2023Jun 30, 2023$692-99.4%
Q2 FY2023CQ1 2023Mar 31, 2023$87.70K-62.6%
Q1 FY2023CQ4 2022Dec 31, 2022$40.74K-88.5%
Q4 FY2022CQ3 2022Sep 30, 2022$51.20K-93.0%
Q3 FY2022CQ2 2022Jun 30, 2022$110.99K-41.0%
Q2 FY2022CQ1 2022Mar 31, 2022$234.67K–
Q1 FY2022CQ4 2021Dec 31, 2021$353.49K–
Q4 FY2021CQ3 2021Sep 30, 2021$727.16K–
Q3 FY2021CQ2 2021Jun 30, 2021$188.18K–
Q2 FY2021CQ1 2021Mar 31, 2021$0–
Q1 FY2021CQ4 2020Dec 31, 2020$0-100.0%
Q4 FY2020CQ3 2020Sep 30, 2020$0-100.0%
Q3 FY2020CQ2 2020Jun 30, 2020$0-100.0%
Q2 FY2020CQ1 2020Mar 31, 2020$0-100.0%
Q1 FY2020CQ4 2019Dec 31, 2019$357-99.1%
Q4 FY2019CQ3 2019Sep 30, 2019$7.86K-2.0%
Q3 FY2019CQ2 2019Jun 30, 2019$1.81K-96.7%
Q2 FY2019CQ1 2019Mar 31, 2019$15.09K-51.4%
Q1 FY2019CQ4 2018Dec 31, 2018$39.10K-85.1%
Q4 FY2018CQ3 2018Sep 30, 2018$8.02K-97.0%
Q3 FY2018CQ2 2018Jun 30, 2018$55.40K-86.2%
Q2 FY2018CQ1 2018Mar 31, 2018$31.07K-72.5%
Q1 FY2018CQ4 2017Dec 31, 2017$261.71K+18.6%
Q4 FY2017CQ3 2017Sep 30, 2017$269.97K+987.6%
Q3 FY2017CQ2 2017Jun 30, 2017$401.63K–
Q2 FY2017CQ1 2017Mar 31, 2017$113.16K–
Q1 FY2017CQ4 2016Dec 31, 2016$220.72K–
Q4 FY2016CQ3 2016Sep 30, 2016$24.82K–

More Regen BioPharma figures

See a number that looks wrong?